| __timestamp | Amphastar Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51256000 | 175000 |
| Thursday, January 1, 2015 | 77347000 | 382000 |
| Friday, January 1, 2016 | 104189000 | 158333 |
| Sunday, January 1, 2017 | 90795000 | 31407709 |
| Monday, January 1, 2018 | 106985000 | 16142321 |
| Tuesday, January 1, 2019 | 131923000 | 168795577 |
| Wednesday, January 1, 2020 | 143340000 | 87992066 |
| Friday, January 1, 2021 | 199739000 | 138287000 |
| Saturday, January 1, 2022 | 248860000 | 232810000 |
| Sunday, January 1, 2023 | 351121000 | 240735000 |
| Monday, January 1, 2024 | 3551000 |
Cracking the code
In the competitive world of pharmaceuticals, Arrowhead Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc. have shown intriguing financial trajectories over the past decade. From 2014 to 2023, Amphastar's gross profit surged by an impressive 585%, peaking in 2023. Meanwhile, Arrowhead experienced a remarkable 137,000% increase from 2014 to 2022, before a notable dip in 2023.
Amphastar consistently outperformed Arrowhead in gross profit, with a significant lead in 2023, reaching a gross profit nearly 46% higher than Arrowhead's. However, Arrowhead's rapid growth from 2017 to 2019, where it saw a 438% increase, highlights its potential in the market.
While 2024 data for Amphastar is unavailable, Arrowhead's figures show a sharp decline, indicating potential challenges ahead. This missing data invites speculation on Amphastar's future performance.
Gross Profit Comparison: Merck & Co., Inc. and Amphastar Pharmaceuticals, Inc. Trends
Amgen Inc. vs Amphastar Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Amphastar Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Amphastar Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Zoetis Inc. vs Amphastar Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing GSK plc and Amphastar Pharmaceuticals, Inc.
Gross Profit Comparison: Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc. Trends
BioMarin Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Corcept Therapeutics Incorporated and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? MorphoSys AG or Arrowhead Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.
Gross Profit Comparison: Amphastar Pharmaceuticals, Inc. and MiMedx Group, Inc. Trends